Ireland
--:--IST
Latest
Clinical Trials in France / NCT03842592
Active, not recruiting Not applicable

Ventricular Arrhythmia After Myocarditis in Sportsman

NCT03842592 · tracked via the Priya Life Science France tracker
Phase
Not applicable
Started
2019-11-06
Last updated
2026-04-06

Condition(s) studied

Myocarditis AcuteVentricular Arrythmia

Investigational drug(s) / intervention(s)

Treadmill Stress test

Treadmill Stress test: Ventricular arrhythmia will be assessed by ECG Holter and during treadmill stress test, both being performed 3 months and 1 year after acute myocarditis

Study summary

The study aims to assess the prevalence of ventricular rhythmic disorder after an acute myocarditis in sportsmen.

50 patients with acute myocarditis, confirmed by MRI, will be assessed by ECG Holter and Treadmill stress test during a 1-year follow-up.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * acute myocarditis, diagnosed on the association of (a) recent viral infection (upper airway, gastro-intestinal) , (b) troponin increase, and (c) chest pain AND myocarditis confirmed by cardiac magnetic resonance 2 out of 3 Lake Louise criteria, either T2 hypersignal, early enhancement or late gadolinium enhancement. * regular physical activity, recreational or competitive: \>=4 hours weekly * written informed consent Exclusion Criteria: * coronary artery disease * acute inflammatory cardiomyopathy (sarcoidosis, fulminant myocarditis, Tako Tsubo, eosinophilic myocarditis, Lyme disease) * history of myocarditis * contra-indication to cardiac MRI * patient unable to perform a treadmill stress test

Primary outcome measure(s)

Trial sites (4)

FacilityCityRegionStatus
Angers University Hospital Angers France
Brest University Hospital Brest France
Lariboisière University Hospital - AP-HP Paris France
Rennes University Hospital Rennes France

More University Hospital, Angers trials in France

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03842592 on ClinicalTrials.gov ↗ ← All trials in France